Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Q3 2024 Mirum Pharmaceuticals Inc Earnings Call Transcript

Nov 12, 2024 / 01:30PM GMT
Release Date Price: $42.28 (+1.61%)
Operator

Hello, everyone and welcome to the Mirum Pharmaceuticals third quarter, 2024 financial results and business update. My name is Seb and I'll be the operator for your call today. If you would like to ask a question during the Q&A session, please press star one on your telephone keypad. If you would like to withdraw your question, please press star two.

I will now hand you over to Andrew mckibbin, Vice President of Investor Relations and Finance. Please go ahead.

Andrew Mckibben
Mirum Pharmaceuticals Inc - IR Contact Officer

Thanks, Seb and Good morning, everyone. I'd like to welcome you to my pharmaceuticals' third quarter, 2024 conference call. I'm joined today by our CEO Chris Peetz, our President and Chief Operating Officer, Peter Radovich, our Chief Medical Officer, Joanne Kwan and Eric Beols, our Chief Financial Officer earlier today, Miriem issued a news release announcing the company's results for the third quarter, 2024 copies of this news release and sec filings can be found in the investors section of our website before we start. I'd like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot